5 November 2023
RNZ's Kim Hill discusses the results of the Malaghan Institute's phase 1 clinical trial.
Michele Leggott / Dr Robert Weinkove / Prof Carl June
Results have been released for Malaghan Institute's ground-breaking CAR T-cell cancer therapy trial, and they are promising.
The therapy reprogrammes a patient's own immune cells to recognise and kill cancer.
Discussing the treatment and trial are Professor Carl June from the University of Pennsylvania who pioneered the therapy and Dr Robert Weinkove, who leads Malaghan's CAR T-cell programme.
They are joined by writer and poet Michele Leggott, who is twelve months into the trial, for an update on her progress.
Related articles
Funding boost to improve lung cancer treatment outcomes in Aotearoa New Zealand
5 September 2025
Read more
Cancer, measles and allergic disease research funded in latest HRC grants round
19 August 2025
Read more
Malaghan cancer research double finalists in KiwiNet Research Commercialisation awards
7 August 2025
Read more
Horizontal mitochondria transfer: 10 years on from a groundbreaking discovery
7 May 2025
Read more
Kjesten Wiig: bringing life-changing treatments to life
27 February 2025
Read more
Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
13 February 2025
Read more